Featured Interventional Oncology Education

Bone Club Webinar series

Join SIO for an intermediate-level (200) musculoskeletal (MSK) and pain webinar series focused on complications, neuromonitoring, procedural safety and best practices for MSK and pain procedures. The series will cover practical strategies for identifying and managing complications, using neuromonitoring to help avoid nerve injury, and applying foundational safety principles to support effective procedural planning and execution.

Using Neuromonitoring to Avoid Complications in MSK and Pain Procedures

Wednesday, 7 October 2026 | 7 – 8:30 p.m. ET

This webinar provides a practical overview of neuromonitoring for musculoskeletal interventions, including thermal ablation. Faculty will review the fundamentals, applications and limitations of neuromonitoring for preventing nerve injury, and discuss available intraoperative neuromonitoring options when services are not directly offered by the hospital.

Faculty

Register

Foundations of Safety and Effectiveness in MSK and Pain Procedures

Wednesday, 28 October 2026 | 7 – 8:30 p.m. ET

This webinar will introduce key safety principles every radiologist should understand when beginning minimally invasive musculoskeletal and pain image-guided procedures. Presented from a multidisciplinary perspective, the session will focus on foundational safety concepts, risk awareness and best practices to support safe procedural planning and execution early in clinical practice.

Faculty

Register

SIO's Bone Club webinar series is sponsored by:

HCC Webinar: Integrating Immunotherapy with Locoregional Therapies in HCC: Mechanisms, Biomarkers, and Resistance

Immunotherapy is reshaping the treatment landscape for hepatocellular carcinoma (HCC). In part two of the HCC webinar series, expert faculty explore how immunotherapy is being integrated with locoregional therapies, including emerging biomarkers, therapeutic targets, treatment resistance and patient perspectives.

Faculty

Watch the Webinar Recording

This webinar is supported by:

Cholangiocarcinoma Foundation

Neuroendocrine Cancer Awareness Network (NCAN) Webinar Recordings

Interventional Treatment For Liver Mets
 

Livestream Q&A with Interventional Radiologist Dr. Sarah White

NETs Get Real with NCAN - Dr. Sarah White!
 

What Are the Current Treatments for Liver Metastases Loco Regional Therapies

Tune In to SIO's Podcast

 Meet The Data Podcast: Conversations with Leading Experts on the Role of HCC and Immunotherapy Podcast Series

This four-part podcast series showcases discussions on pivotal trials that established immunotherapy’s role in advanced HCC. Search for the “Society of Interventional Oncology Podcast” in your favorite podcast app. Supported by an educational grant from AstraZeneca. 

HCC Focus

Landmark trials in hepatocellular carcinoma

Immunotherapy

Cutting-edge treatments

Expert Insights

Listen on-demand

Listen on Spotify Listen on Apple

Episode One — Local Therapy vs. Combination Therapy: What’s Changing in Liver Cancer Treatment?

Join experts Chris Malone, MD and Lingling Du, MD as they explore the evolving landscape of liver cancer treatment. Moderated by Edward Kim, MD and Cynthia De la Garza, MD this episode dives into the latest clinical evidence supporting combination therapies and discusses the real-world challenges of implementing them. Learn how patient selection, tumor biology, and treatment risks are shaping the future of care.

Listen on Spotify Listen on Apple

Episode Two — Comparing LEAP-012 vs. EMERALD-1 Study: Decoding the Data

What do two of the most talked-about liver cancer trials reveal about the future of immunotherapy? Riad Salem, MD, MBA and Stephen Chan, MBBS, MRCP, FHKCP, FHKAM, FRCP, FRCP, MD discuss the LEAP-012 and EMERALD-1 studies with moderators  Venkatesh Krishmasamy, MD, and Sean Golden, MD. This episode compares trial designs, outcomes, and implications for clinical practice—offering insights into how these findings could reshape treatment protocols.

Listen on Spotify Listen on Apple

Episode Three — Role of (neo)adjuvant immunotherapy pre-transplant vs. Adjuvant immunotherapy post-transplant

Should immunotherapy come before or after transplant? Experts Parissa Tabrizian, MD and Beau Toskich, MD explore one of the most critical questions in transplant oncology: when is the right time to introduce immunotherapy? Moderated by Bill Rilling, MD, the discussion dives into the clinical evidence surrounding neoadjuvant and adjuvant immuno-oncology (IO) therapies in transplant settings.

Listen on Spotify Listen on Apple

Episode Four — Ablation vs. Ablation + Combination Immune Therapy

Is combining ablation with immune therapy lead to better outcomes? Gentry King, MD and Isabel Newton, MD explore this question with moderators Elena Violari, MD and Greg Pommier. Discover how the synergy between local and systemic treatments is being studied, and what it means for patient selection, recurrence rates, and long-term survival.

Listen on Spotify Listen on Apple